Confluent, Inc. 8-K Filing

FAQ

Key Financial Figures

• $0.00001 — tered Class A Common Stock, par value $0.00001 per share CFLT The Nasdaq Stock Mar
• $31.00 — and converted into the right to receive $31.00 in cash, without interest (the "Per Sha
• $453,600,000 — equired to pay IBM a termination fee of $453,600,000. Specifically, this termination fee is

Filing Documents

• tm2532777d2_8k.htm (8-K) — 78KB
• tm2532777d2_ex2-1.htm (EX-2.1) — 633KB
• tm2532777d2_ex10-1.htm (EX-10.1) — 92KB
• tm2532777d2_ex99-1.htm (EX-99.1) — 28KB
• 0001104659-25-119081.txt ( ) — 1171KB
• cflt-20251207.xsd (EX-101.SCH) — 3KB
• cflt-20251207_lab.xml (EX-101.LAB) — 33KB
• cflt-20251207_pre.xml (EX-101.PRE) — 22KB
• tm2532777d2_8k_htm.xml (XML) — 3KB

Forward Looking Statements

Forward Looking Statements This communication contains "forward-looking Act of 1995. All statements other than statements of historical fact are statements that could be deemed "forward-looking statements", including all statements regarding the intent, belief or current expectation of the companies and members of their senior management teams. Words such as "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "project," "potential," "continue," "target," variations of such words, and similar expressions are intended to identify such forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements include, but are not limited to, statements regarding the benefits of and timeline for closing the Company's proposed transaction with IBM. These management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive Many actual events and circumstances are beyond the control of the Company. These forward-looking statements are subject to a number of risks and uncertainties, including the timing, receipt and terms and conditions of any required governmental and regulatory approvals of the proposed transaction that could delay the consummation of the proposed transaction or cause the parties to abandon the proposed transaction; the occurrence o

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 2.1* Agreement and Plan of Merger, dated as of December 7, 2025, by and among International Business Machines Corporation, Corvo Merger Sub, Inc. and Confluent, Inc. 10.1* Voting Agreement, dated as of December 7, 2025, by and among International Business Machines Corporation, Corvo Merger Sub, Inc., Confluent, Inc. and the persons listed on Schedule A thereto who are signatories to such agreement 99.1 Joint Press Release 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) * Schedules and exhibits omitted pursuant to Item 601(a)(5) of Regulation S-K. Confluent will furnish supplementally a copy of any omitted schedule or exhibit to the Securities and Exchange Commission upon request. Confluent may request confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended, for any schedules or exhibits so furnished. 7

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CONFLUENT, INC. By: /s/ Edward Jay Kreps Dated: December 8, 2025 Edward Jay Kreps Chief Executive Officer 8

View Full Filing

View this 8-K filing on SEC EDGAR